期刊文献+

光学相干断层扫描成像在息肉样脉络膜血管病变临床诊疗中的应用和问题

Application and problems of optical coherence tomography in clinical diagnosis and treatment of polypoidal choroidal vasculopathy
原文传递
导出
摘要 息肉样脉络膜血管病变(PCV)是一种可造成严重视力损害的眼底疾病。目前诊断PCV的金标准是吲哚菁绿血管造影成像(ICGA),介于其有创性和临床应用的不便性,研究者正探索将无创的光学相干断层扫描(OCT)用于PCV的临床诊断和随访,也逐渐涌现了基于OCT的无创化诊断标准;但临床在应用该技术时,还存在成像效果不理想、诊断不明确、过度依赖OCT技术、随访情况复杂等问题。本文拟对OCT在PCV临床诊疗应用的现状、新的诊断标准和相关方面存在的问题进行述评,以期为眼科同道提供参考。 Polypoidal choroidal vasculopathy(PCV)is a fundus disease that can cause severe visual impairment.At present,the gold standard for the diagnosis of PCV is indocyanine green angiography(ICGA).Due to its invasiveness and inconvenience in clinical application,researchers are exploring the use of non-invasive optical coherence tomography(OCT)in clinical diagnosis and follow-up of PCV,and non-invasive diagnostic criteria based on OCT are gradually emerging.However,in the clinical application of this technology,there are still some problems,such as poor imaging effect,unclear diagnosis,over-reliance on OCT technology,complex follow-up situations and so on.This paper intends to review the current situation,new diagnostic criteria and related problems of OCT in the clinical diagnosis and treatment of PCV,in order to provide reference for ophthalmologists.
作者 陈有信 古兴旺 Chen Youxin;Gu Xingwang(Department of Ophthalmology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)
出处 《中国医师杂志》 CAS 2023年第4期491-495,共5页 Journal of Chinese Physician
基金 国家自然科学基金(82271112)。
关键词 体层摄影术 光学相干 息肉样脉络膜血管病变 荧光素血管造影术 Tomography,optical coherence Polypoidal choroidal vasculopathy Fluorescein angiography
  • 相关文献

参考文献2

二级参考文献26

  • 1文峰,吴德正,陈艳丽,孙祖华,黄时洲,罗光伟,关天芹,刘彩娇.渗出型老年性黄斑变性与息肉状脉络膜血管病变眼底形态学的对比分析[J].中华眼底病杂志,2004,20(5):307-309. 被引量:13
  • 2张承芬.眼底荧光血管造影[A].张承芬 主编.眼底病学[C].北京:人民卫生出版社,1998.88-117.
  • 3黄时洲,吴德正.吲哚菁绿血管造影的正常与异常荧光形态.见:吴德正,主编.眼部吲哚菁绿血管造影学.沈阳:辽宁科学技术出版社,2002.60-100.
  • 4! Yannuzzi IrA, Sorenson J, Spaide RF, et al., IdiopathicI polypoidal choroidal vasculopathy (IPCV). Retina, 1990,10 : 1-8.
  • 5Byeon SH, Lee SC, Oh HS,et al. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol, 2008,52 : 57-62.
  • 6Liu Y, Wen F, Huang S, et al. Subtype lesions of neovascular age-related maeular degeneration in Chinese patients. Graefe's Arch Clin Exp Ophthalmol, 2007,245: 1441-1445.
  • 7Tong JP, Chan WM, Liu DT, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium- derived factor in polypoidal choroidal vasculopathy and choroidal neovaseularization. Am J Ophthalmol, 2006,141 : 456-462.
  • 8Tsujikawa A, Nakanishi H, Ojima Y,et al. Macular polypoidalchoroidal vasculopathy with a remote lesion. Clin Experiment Ophthalmol, 2008,36 : 817-823.
  • 9Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nihon Ganka Gakkai Zasshi, 2005, 109:417-427.
  • 10Kwok AK, Lai TY, Chan CW, et al. Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol, 2002,86: 892-897.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部